Navneet Sanghera
Overview
Explore the profile of Navneet Sanghera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Qu Y, Cheng C, Tsai P, Edwards K, Xue S, et al.
Mol Metab
. 2023 Jul;
75:101770.
PMID: 37423391
Objective: The activation of non-shivering thermogenesis (NST) has strong potential to combat obesity and metabolic disease. The activation of NST however is extremely temporal and the mechanisms surrounding how the...
2.
Ambrosy A, Parikh R, Sung S, Tan T, Narayanan A, Masson R, et al.
J Am Coll Cardiol
. 2022 Jul;
80(2):111-122.
PMID: 35798445
Background: There is growing interest to disentangle worsening heart failure (WHF) from location of care and move away from hospitalization as a surrogate for acuity. Objectives: The purpose of this...
3.
Hur P, Yi E, Ionescu-Ittu R, Manceur A, Lomax K, Cammarota J, et al.
Rheumatol Ther
. 2021 Dec;
9(1):265-283.
PMID: 34874547
Introduction: The aim of this study was to understand the reasons for canakinumab initiation among patients with Still's disease, including systemic juvenile idiopathic arthritis (SJIA) and adult-onset Still's disease (AOSD),...
4.
Ambrosy A, Parikh R, Sung S, Narayanan A, Masson R, Lam P, et al.
JAMA Netw Open
. 2021 Nov;
4(11):e2135152.
PMID: 34807259
Importance: The current understanding of epidemiological mechanisms and temporal trends in hospitalizations for worsening heart failure (WHF) is based on claims and national reporting databases. However, these data sources are...
5.
Hur P, Lomax K, Ionescu-Ittu R, Manceur A, Xie J, Cammarota J, et al.
Pediatr Rheumatol Online J
. 2021 Sep;
19(1):143.
PMID: 34521444
Background: Although canakinumab has demonstrated efficacy in multiple trials in patients with periodic fever syndromes (PFS), the evidence on initiation of canakinumab among PFS patients in real world setting is...
6.
Belhorma K, Darwish N, Benn-Hirsch E, Duenas A, Gates H, Sanghera N, et al.
Alcohol
. 2021 May;
94:65-73.
PMID: 33961967
Alcohol is a known teratogen, and developmental exposure to ethanol results in fetal alcohol spectrum disorder (FASD). Children born with FASD can exhibit a range of symptoms including low birth...
7.
Sanghera N, Chan P, Khaki Z, Planner C, Lee K, Cranswick N, et al.
Drug Saf
. 2006 Oct;
29(11):1031-47.
PMID: 17061909
Medicines' management or pharmaceutical care in paediatric patients is particularly demanding, mainly because the majority of available drugs have been developed for use in adults. As a result, in children,...